+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiologic testing in patients with the long QT syndrome

Circulation 71(1): 63-71
Electrophysiologic testing in patients with the long QT syndrome
Electrophysiologic studies were performed in 15 patients with syncope and/or cardiac arrest who had the long QT syndrome and 11 control subjects who had normal QT intervals. The syndrome was familial in five patients and idiopathic in 10. All patients had a prolonged QT (546 +/- 68 msec, mean +/- SD) and corrected QT (550 +/- 51 msec). Incremental atrial pacing at cycle lengths of 600 to 400 msec resulted in shortening of the QT interval, but there was no significant difference in the magnitude or percent of shortening of the QT interval between patients with the long QT syndrome and control subjects. Intravenous propranolol did not influence the QT interval measured at fixed atrial-paced cycle lengths in patients with either the familial or idiopathic form of the syndrome. Programmed right and left ventricular stimulation with up to three extrastimuli before and during isoproterenol infusion did not induce sustained ventricular tachycardia or ventricular fibrillation in any of the patients. However, rapid polymorphic nonsustained ventricular tachycardia was induced in six of the 15 patients (40%). Neither the inducibility of nonsustained ventricular tachycardia nor the results of electropharmacologic testing with beta-blockers proved to be of any prognostic value during the mean follow-up period of 28 +/- 17 months. Electrophysiologic studies are of limited value in the diagnosis and treatment of patients with the long QT syndrome.

Accession: 005349368

PMID: 2856866

DOI: 10.1161/01.CIR.71.1.63

Related references

Value of electrophysiologic testing in long term follow up of patients with syncope of unknown cause. Giornale Italiano di Cardiologia 17(5): 402-407, 1987

Electrophysiologic testing predicts events in Brugada syndrome patients. Heart Rhythm 8(10): 1595-1597, 2012

Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing. Journal of the American College of Cardiology 2(6): 1053-1059, 1983

Long term survival in patients with malignant ventricular tachyarrhythmias non inducible at electrophysiologic testing. European Heart Journal 8(ABSTR SUPPL 2): 51, 1987

Electrophysiologic testing in the management of patients with the Wolff-Parkinson-White syndrome and atrial fibrillation. American Journal of Cardiology 51(10): 1623-1628, 1983

Results of electrophysiologic testing and long-term prognosis in patients with coronary artery disease and aborted sudden death. American Heart Journal 122(4 Pt 1): 1001-1006, 1991

Long term follow up of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs selected by electrophysiologic testing. Clinical Research 36(3): 296A, 1988

Predictive value of early electrophysiologic testing in determining long-term outcome with amiodarone treatment in patients with sustained ventricular tachycardia. Mayo Clinic Proceedings 66(11): 1114-1119, 1991

Long term greater than 3 years variability of the electrophysiologic pattern in patients with the wpw syndrome. European Heart Journal 11(ABSTR SUPPL): 302, 1990

Electrophysiologic studies in patients with unexplained syncope and long-term outcome after therapy guided by electrophysiologic results. European Heart Journal 16(ABSTR SUPPL ): 379, 1995